开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2138760, encodeId=72df2138e6039, content=偏重的研究方向：脑血管;纯生信 经验分享：纯生信的文章好投吗，关于卒中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:37:17 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1213071, encodeId=a88b12130e194, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;细胞实验 经验分享：投出去5天被拒，理由是优先级不够，瑞士杂志非常严谨，需要所有作者的邮箱，并要求所有作者通过邮件确认可以投稿，流程很麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Thu Apr 21 10:13:47 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581062, encodeId=8950581062fb, content=同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, beContent=LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2bd5241971, createdName=147c1e0am87暂无昵称, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013334, encodeId=f3c6101333450, content=病例报告好投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3d65582752, createdName=ms6000000786765056, createdTime=Tue Aug 31 23:55:12 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191775, encodeId=96ca1191e75f1, content=请问为什么European neurology官网常常打不开呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06470128, createdName=ms4000001518821418, createdTime=Thu Feb 10 12:18:58 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090346, encodeId=d72610903461a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090345, encodeId=f50d10903459a, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585309, encodeId=3650585309a3, content=这个杂志版面费大概多少钱？152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, beContent=152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77155286301, createdName=148535fcm60暂无昵称, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584374, encodeId=d7ed5843e4de, content=同问，您投过这个杂志吗178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, beContent=178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200812/3859dc0233744838956030acc9368650/4aac6f4905cd470a9de16ee2b5a8ecb2.jpg, createdBy=bbdb5155674, createdName=piggy, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542112, encodeId=0f6d54211284, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2023-05-24 ms7000000275097926 来自浙江省

偏重的研究方向：脑血管;纯生信
经验分享：纯生信的文章好投吗，关于卒中的

82 0

[GetPortalCommentsPageByObjectIdResponse(id=2138760, encodeId=72df2138e6039, content=偏重的研究方向：脑血管;纯生信 经验分享：纯生信的文章好投吗，关于卒中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:37:17 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1213071, encodeId=a88b12130e194, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;细胞实验 经验分享：投出去5天被拒，理由是优先级不够，瑞士杂志非常严谨，需要所有作者的邮箱，并要求所有作者通过邮件确认可以投稿，流程很麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Thu Apr 21 10:13:47 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581062, encodeId=8950581062fb, content=同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, beContent=LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2bd5241971, createdName=147c1e0am87暂无昵称, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013334, encodeId=f3c6101333450, content=病例报告好投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3d65582752, createdName=ms6000000786765056, createdTime=Tue Aug 31 23:55:12 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191775, encodeId=96ca1191e75f1, content=请问为什么European neurology官网常常打不开呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06470128, createdName=ms4000001518821418, createdTime=Thu Feb 10 12:18:58 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090346, encodeId=d72610903461a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090345, encodeId=f50d10903459a, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585309, encodeId=3650585309a3, content=这个杂志版面费大概多少钱？152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, beContent=152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77155286301, createdName=148535fcm60暂无昵称, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584374, encodeId=d7ed5843e4de, content=同问，您投过这个杂志吗178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, beContent=178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200812/3859dc0233744838956030acc9368650/4aac6f4905cd470a9de16ee2b5a8ecb2.jpg, createdBy=bbdb5155674, createdName=piggy, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542112, encodeId=0f6d54211284, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2022-04-21 ms5000001157259702

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：免疫;肿瘤;细胞实验
经验分享：投出去5天被拒，理由是优先级不够，瑞士杂志非常严谨，需要所有作者的邮箱，并要求所有作者通过邮件确认可以投稿，流程很麻烦。

102 0

[GetPortalCommentsPageByObjectIdResponse(id=2138760, encodeId=72df2138e6039, content=偏重的研究方向：脑血管;纯生信 经验分享：纯生信的文章好投吗，关于卒中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:37:17 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1213071, encodeId=a88b12130e194, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;细胞实验 经验分享：投出去5天被拒，理由是优先级不够，瑞士杂志非常严谨，需要所有作者的邮箱，并要求所有作者通过邮件确认可以投稿，流程很麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Thu Apr 21 10:13:47 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581062, encodeId=8950581062fb, content=同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, beContent=LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2bd5241971, createdName=147c1e0am87暂无昵称, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013334, encodeId=f3c6101333450, content=病例报告好投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3d65582752, createdName=ms6000000786765056, createdTime=Tue Aug 31 23:55:12 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191775, encodeId=96ca1191e75f1, content=请问为什么European neurology官网常常打不开呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06470128, createdName=ms4000001518821418, createdTime=Thu Feb 10 12:18:58 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090346, encodeId=d72610903461a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090345, encodeId=f50d10903459a, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585309, encodeId=3650585309a3, content=这个杂志版面费大概多少钱？152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, beContent=152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77155286301, createdName=148535fcm60暂无昵称, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584374, encodeId=d7ed5843e4de, content=同问，您投过这个杂志吗178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, beContent=178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200812/3859dc0233744838956030acc9368650/4aac6f4905cd470a9de16ee2b5a8ecb2.jpg, createdBy=bbdb5155674, createdName=piggy, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542112, encodeId=0f6d54211284, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2019-12-06 147c1e0am87暂无昵称

同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！LoveSCI 2015-12-03 19:42:00 发表:
2015年11月16号投稿，19号under review

LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review

204 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138760, encodeId=72df2138e6039, content=偏重的研究方向：脑血管;纯生信 经验分享：纯生信的文章好投吗，关于卒中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:37:17 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1213071, encodeId=a88b12130e194, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;细胞实验 经验分享：投出去5天被拒，理由是优先级不够，瑞士杂志非常严谨，需要所有作者的邮箱，并要求所有作者通过邮件确认可以投稿，流程很麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Thu Apr 21 10:13:47 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581062, encodeId=8950581062fb, content=同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, beContent=LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2bd5241971, createdName=147c1e0am87暂无昵称, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013334, encodeId=f3c6101333450, content=病例报告好投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3d65582752, createdName=ms6000000786765056, createdTime=Tue Aug 31 23:55:12 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191775, encodeId=96ca1191e75f1, content=请问为什么European neurology官网常常打不开呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06470128, createdName=ms4000001518821418, createdTime=Thu Feb 10 12:18:58 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090346, encodeId=d72610903461a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090345, encodeId=f50d10903459a, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585309, encodeId=3650585309a3, content=这个杂志版面费大概多少钱？152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, beContent=152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77155286301, createdName=148535fcm60暂无昵称, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584374, encodeId=d7ed5843e4de, content=同问，您投过这个杂志吗178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, beContent=178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200812/3859dc0233744838956030acc9368650/4aac6f4905cd470a9de16ee2b5a8ecb2.jpg, createdBy=bbdb5155674, createdName=piggy, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542112, encodeId=0f6d54211284, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2021-08-31 ms6000000786765056

病例报告好投吗？

111 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138760, encodeId=72df2138e6039, content=偏重的研究方向：脑血管;纯生信 经验分享：纯生信的文章好投吗，关于卒中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:37:17 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1213071, encodeId=a88b12130e194, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;细胞实验 经验分享：投出去5天被拒，理由是优先级不够，瑞士杂志非常严谨，需要所有作者的邮箱，并要求所有作者通过邮件确认可以投稿，流程很麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Thu Apr 21 10:13:47 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581062, encodeId=8950581062fb, content=同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, beContent=LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2bd5241971, createdName=147c1e0am87暂无昵称, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013334, encodeId=f3c6101333450, content=病例报告好投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3d65582752, createdName=ms6000000786765056, createdTime=Tue Aug 31 23:55:12 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191775, encodeId=96ca1191e75f1, content=请问为什么European neurology官网常常打不开呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06470128, createdName=ms4000001518821418, createdTime=Thu Feb 10 12:18:58 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090346, encodeId=d72610903461a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090345, encodeId=f50d10903459a, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585309, encodeId=3650585309a3, content=这个杂志版面费大概多少钱？152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, beContent=152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77155286301, createdName=148535fcm60暂无昵称, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584374, encodeId=d7ed5843e4de, content=同问，您投过这个杂志吗178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, beContent=178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200812/3859dc0233744838956030acc9368650/4aac6f4905cd470a9de16ee2b5a8ecb2.jpg, createdBy=bbdb5155674, createdName=piggy, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542112, encodeId=0f6d54211284, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2022-02-10 ms4000001518821418

请问为什么European neurology官网常常打不开呀?

96 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138760, encodeId=72df2138e6039, content=偏重的研究方向：脑血管;纯生信 经验分享：纯生信的文章好投吗，关于卒中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:37:17 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1213071, encodeId=a88b12130e194, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;细胞实验 经验分享：投出去5天被拒，理由是优先级不够，瑞士杂志非常严谨，需要所有作者的邮箱，并要求所有作者通过邮件确认可以投稿，流程很麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Thu Apr 21 10:13:47 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581062, encodeId=8950581062fb, content=同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, beContent=LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2bd5241971, createdName=147c1e0am87暂无昵称, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013334, encodeId=f3c6101333450, content=病例报告好投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3d65582752, createdName=ms6000000786765056, createdTime=Tue Aug 31 23:55:12 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191775, encodeId=96ca1191e75f1, content=请问为什么European neurology官网常常打不开呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06470128, createdName=ms4000001518821418, createdTime=Thu Feb 10 12:18:58 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090346, encodeId=d72610903461a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090345, encodeId=f50d10903459a, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585309, encodeId=3650585309a3, content=这个杂志版面费大概多少钱？152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, beContent=152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77155286301, createdName=148535fcm60暂无昵称, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584374, encodeId=d7ed5843e4de, content=同问，您投过这个杂志吗178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, beContent=178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200812/3859dc0233744838956030acc9368650/4aac6f4905cd470a9de16ee2b5a8ecb2.jpg, createdBy=bbdb5155674, createdName=piggy, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542112, encodeId=0f6d54211284, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2021-12-29 MS54455111222

摘要和HIGHLIGHTS的区别？

93 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138760, encodeId=72df2138e6039, content=偏重的研究方向：脑血管;纯生信 经验分享：纯生信的文章好投吗，关于卒中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:37:17 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1213071, encodeId=a88b12130e194, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;细胞实验 经验分享：投出去5天被拒，理由是优先级不够，瑞士杂志非常严谨，需要所有作者的邮箱，并要求所有作者通过邮件确认可以投稿，流程很麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Thu Apr 21 10:13:47 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581062, encodeId=8950581062fb, content=同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, beContent=LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2bd5241971, createdName=147c1e0am87暂无昵称, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013334, encodeId=f3c6101333450, content=病例报告好投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3d65582752, createdName=ms6000000786765056, createdTime=Tue Aug 31 23:55:12 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191775, encodeId=96ca1191e75f1, content=请问为什么European neurology官网常常打不开呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06470128, createdName=ms4000001518821418, createdTime=Thu Feb 10 12:18:58 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090346, encodeId=d72610903461a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090345, encodeId=f50d10903459a, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585309, encodeId=3650585309a3, content=这个杂志版面费大概多少钱？152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, beContent=152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77155286301, createdName=148535fcm60暂无昵称, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584374, encodeId=d7ed5843e4de, content=同问，您投过这个杂志吗178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, beContent=178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200812/3859dc0233744838956030acc9368650/4aac6f4905cd470a9de16ee2b5a8ecb2.jpg, createdBy=bbdb5155674, createdName=piggy, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542112, encodeId=0f6d54211284, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2021-12-28 小动量

highlights部分的一般要求是什么？

86 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138760, encodeId=72df2138e6039, content=偏重的研究方向：脑血管;纯生信 经验分享：纯生信的文章好投吗，关于卒中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:37:17 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1213071, encodeId=a88b12130e194, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;细胞实验 经验分享：投出去5天被拒，理由是优先级不够，瑞士杂志非常严谨，需要所有作者的邮箱，并要求所有作者通过邮件确认可以投稿，流程很麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Thu Apr 21 10:13:47 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581062, encodeId=8950581062fb, content=同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, beContent=LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2bd5241971, createdName=147c1e0am87暂无昵称, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013334, encodeId=f3c6101333450, content=病例报告好投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3d65582752, createdName=ms6000000786765056, createdTime=Tue Aug 31 23:55:12 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191775, encodeId=96ca1191e75f1, content=请问为什么European neurology官网常常打不开呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06470128, createdName=ms4000001518821418, createdTime=Thu Feb 10 12:18:58 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090346, encodeId=d72610903461a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090345, encodeId=f50d10903459a, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585309, encodeId=3650585309a3, content=这个杂志版面费大概多少钱？152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, beContent=152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77155286301, createdName=148535fcm60暂无昵称, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584374, encodeId=d7ed5843e4de, content=同问，您投过这个杂志吗178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, beContent=178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200812/3859dc0233744838956030acc9368650/4aac6f4905cd470a9de16ee2b5a8ecb2.jpg, createdBy=bbdb5155674, createdName=piggy, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542112, encodeId=0f6d54211284, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2020-02-25 148535fcm60暂无昵称

这个杂志版面费大概多少钱？152****6089暂无昵称 2020-02-07 00:00:00 发表:
同问，您投过这个杂志吗

152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗

181 0

[GetPortalCommentsPageByObjectIdResponse(id=2138760, encodeId=72df2138e6039, content=偏重的研究方向：脑血管;纯生信 经验分享：纯生信的文章好投吗，关于卒中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:37:17 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1213071, encodeId=a88b12130e194, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;细胞实验 经验分享：投出去5天被拒，理由是优先级不够，瑞士杂志非常严谨，需要所有作者的邮箱，并要求所有作者通过邮件确认可以投稿，流程很麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Thu Apr 21 10:13:47 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581062, encodeId=8950581062fb, content=同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, beContent=LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2bd5241971, createdName=147c1e0am87暂无昵称, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013334, encodeId=f3c6101333450, content=病例报告好投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3d65582752, createdName=ms6000000786765056, createdTime=Tue Aug 31 23:55:12 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191775, encodeId=96ca1191e75f1, content=请问为什么European neurology官网常常打不开呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06470128, createdName=ms4000001518821418, createdTime=Thu Feb 10 12:18:58 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090346, encodeId=d72610903461a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090345, encodeId=f50d10903459a, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585309, encodeId=3650585309a3, content=这个杂志版面费大概多少钱？152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, beContent=152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77155286301, createdName=148535fcm60暂无昵称, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584374, encodeId=d7ed5843e4de, content=同问，您投过这个杂志吗178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, beContent=178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200812/3859dc0233744838956030acc9368650/4aac6f4905cd470a9de16ee2b5a8ecb2.jpg, createdBy=bbdb5155674, createdName=piggy, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542112, encodeId=0f6d54211284, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2020-02-07 piggy

同问，您投过这个杂志吗178****1987暂无昵称 2019-12-06 00:00:00 发表:
同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！

178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！

173 0

[GetPortalCommentsPageByObjectIdResponse(id=2138760, encodeId=72df2138e6039, content=偏重的研究方向：脑血管;纯生信 经验分享：纯生信的文章好投吗，关于卒中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:37:17 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1213071, encodeId=a88b12130e194, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;细胞实验 经验分享：投出去5天被拒，理由是优先级不够，瑞士杂志非常严谨，需要所有作者的邮箱，并要求所有作者通过邮件确认可以投稿，流程很麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Thu Apr 21 10:13:47 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581062, encodeId=8950581062fb, content=同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, beContent=LoveSCI 2015-12-03 19:42:00 发表: 2015年11月16号投稿，19号under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2bd5241971, createdName=147c1e0am87暂无昵称, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013334, encodeId=f3c6101333450, content=病例报告好投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3d65582752, createdName=ms6000000786765056, createdTime=Tue Aug 31 23:55:12 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191775, encodeId=96ca1191e75f1, content=请问为什么European neurology官网常常打不开呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06470128, createdName=ms4000001518821418, createdTime=Thu Feb 10 12:18:58 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090346, encodeId=d72610903461a, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090345, encodeId=f50d10903459a, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585309, encodeId=3650585309a3, content=这个杂志版面费大概多少钱？152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, beContent=152****6089暂无昵称 2020-02-07 00:00:00 发表: 同问，您投过这个杂志吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77155286301, createdName=148535fcm60暂无昵称, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584374, encodeId=d7ed5843e4de, content=同问，您投过这个杂志吗178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, beContent=178****1987暂无昵称 2019-12-06 00:00:00 发表: 同学您好！请问你之前投的european neurology 中了吗？版面费是如何交的啊！跪谢！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200812/3859dc0233744838956030acc9368650/4aac6f4905cd470a9de16ee2b5a8ecb2.jpg, createdBy=bbdb5155674, createdName=piggy, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542112, encodeId=0f6d54211284, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2017-07-14 qiqi

从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有

352 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务